It is noteworthy that in both PD patients and non-demented controls, DAT is co-expressed with transcriptional factors FOXA1/2, LMX1A/B, and EN2 involved in dopaminergic neuron development. The gene discussed is SLC6A3; the disease is Parkinson disease.